Trial CTSU-A031702


A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)

Type: Treatment
Phase: Phase II
Status: Open to Accrual
Treatments: Chemotherapy: Systemic, Immunotherapy
Randomized: No
USC Satellite Location: USC Newport Beach Oncology
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Anishka D'Souza, M.D.
Other Trial Staff:  Aaron Mejia, Coordinator, Cheryl Kefauver, Coordinator, Monica Flores, D.M., Lagrimas Ilagan, D.M., Mary Ordaz, D.M., Roberto Tejada, Coordinator, Shamim Jhimlee, Coordinator, Honorina Enright, D.M., Amanda Luna, Coordinator, Niranjan Bhatt, D.M., Meena Ibrahim, D.M., Bartolo Santos, Coordinator, Aubrianne Cho, Coordinator, Thomas Elimihele, D.M., Viviana Moreno, D.M., Mayra Vergara, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.